Sun Pharma announces positive Phase III results for Nidlegy in locally advanced fully resectable melanoma patients Ruchika Sharma16 Oct 2023 2:49 PM ISTNidlegy is also being developed in dedicated Phase II clinical trials for the treatment of aggressive forms of non-melanoma skin cancer, including...
Sun Pharma Cequa Phase 4 data shows sustained improvement in Dry Eye Disease signs, symptoms in patients switched from Restasis Ruchika Sharma13 Oct 2023 2:29 PM ISTMumbai: Sun Pharmaceutical Industries Limited has announced the presentation of Phase 4 data showing that CEQUA (cyclosporine ophthalmic solution)...
Aurobindo Pharma, Sun Pharma recall Rasagiline Tablets, Cequa from US market Ruchika Sharma9 Oct 2023 12:30 PM ISTThe US health regulator stated that Aurobindo Pharma is recalling 9,890 bottles of Rasagiline Tablets, a medication indicated for the treatment of...
CDSCO panel opines Sun Pharma to submit more safety data of Ranibizumab Solution for Injection Dr. Divya Colin8 Oct 2023 6:00 PM ISTNew Delhi: Responding to the proposal presented by the pharmaceutical major Sun Pharma for approval of additional indications for the already approved...
USFDA accepts Sun Pharma NDA for alopecia areata drug Deuruxolitinib Ruchika Sharma6 Oct 2023 1:52 PM ISTMumbai: Sun Pharmaceutical Industries Ltd has announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application...
Sun Pharma to buy out local partner Indi Pharma from Mexican arm for over Rs 75 crore Ruchika Sharma30 Sept 2023 3:30 PM ISTNew Delhi: Sun Pharmaceutical Industries Ltd on Thursday said it will buy out local partner Indi Pharma from its Mexican arm for MXN 161.85 million...
Sun Pharma topical acne treatment Winlevi now available in Canada Ruchika Sharma28 Sept 2023 11:25 AM ISTMumbai: Sun Pharma Canada Inc., a wholly-owned subsidiary of Sun Pharmaceutical Industries Limited has announced that WINLEVI (clascoterone cream...
LIC sells over 2 percent stake in Sun Pharma for Rs 4699 crore via open market sale Ruchika Sharma15 Sept 2023 12:39 PM ISTThe shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction,...
Sun Pharma gets rights for marketing cerebral ischemic stroke drug Sovateltide under brand name Tyvalzi in India Ruchika Sharma14 Sept 2023 1:30 PM ISTMumbai: Sun Pharmaceutical Industries Limited today announced that one of its wholly-owned subsidiaries has entered into a license agreement with...
Sun Pharma aims to spend 7-8 percent of sales in current fiscal on RnD Ruchika Sharma29 Aug 2023 1:00 PM ISTAccording to Shanghvi, the domestic pharmaceutical market size is estimated to reach USD 35-39 billion by 2027, recording 7.5-10.5 per cent compounded...
Sun Pharma looking to fully acquire Israel based unit Taro Pharmaceutical Industries: MD Dilip Shanghvi Ruchika Sharma28 Aug 2023 1:30 PM ISTSun Pharma currently owns around 78 per cent stake in Taro.
Trademark Infringement Suit: Delhi HC awards Rs 5 lakh cost to Sun Pharma over Oxiplat mark Farhat Nasim9 Aug 2023 6:51 PM ISTNew Delhi: Ruling in favour of Sun Pharmaceuticals Ltd. (Sun Pharma), Delhi High Court has awarded costs of Rs 5 lakh to the drug giant in a trademark...
